| LSB | LakeShore Biopharma Co Ltd | 0.03 | -99.56% |
| NTBL | Notable Labs Inc Ord | 0.03 | -99.42% |
| TNFA | TNF Pharmaceuticals Inc | 0.05 | -99.20% |
| QLGN | Qualigen Therapeutics, Inc. Common Stock | 0.05 | -99.08% |
| AFMD | Affimed N.V. | 0.06 | -98.94% |
| EPIX | Essa Pharma Inc | 0.08 | -98.61% |
| ENLV | Enlivex Therapeutics Ltd | 0.08 | -98.59% |
| ONCO | Onconetix Inc | 0.09 | -98.45% |
| PBM | Psyence Biomedical Ltd | 0.12 | -98.05% |
| OSRH | Bellevue Life Sciences Acquisition Corp | 0.14 | -97.61% |
| PPBT | Purple Biotech Ltd | 0.14 | -97.56% |
| BDRX | Biodexa Pharmaceuticals Plc | 0.15 | -97.50% |
| ENTO | Entero Therapeutics, Inc. Common Stock | 0.15 | -97.41% |
| ONCT | Oncternal Therapeutics Inc | 0.17 | -97.12% |
| PPCB | Propanc Biopharma Inc | 0.18 | -96.87% |
| PMCB | PharmaCyte Biotech Inc | 0.20 | -96.70% |
| APRE | Aprea Therapeutics Inc | 0.22 | -96.28% |
| GLMD | Galmed Pharmaceuticals Ltd | 0.25 | -95.80% |
| CTXR | Citius Pharmaceuticals Inc | 0.25 | -95.80% |
| NCNA | NuCana plc | 0.28 | -95.35% |
| NXTC | Nextcure Inc | 0.29 | -95.01% |
| REVB | Revelation Biosciences Inc | 0.31 | -94.80% |
| APM | Aptorum Group Ltd - Class A | 0.31 | -94.70% |
| AZTR | Azitra Inc | 0.33 | -94.47% |
| MGX | Metagenomi Inc | 0.34 | -94.30% |
| KTTA | Pasithea Therapeutics Corp | 0.36 | -93.98% |
| BOLD | Boundless Bio Inc | 0.36 | -93.92% |
| SEER | Seer Inc - Class A | 0.39 | -93.48% |
| GRI | GRI Bio Inc | 0.39 | -93.48% |
| ENGN | enGene Holdings Inc | 0.40 | -93.28% |
| ELAB | PMGC Holdings Inc | 0.40 | -93.23% |
| GNPX | Genprex Inc | 0.41 | -92.99% |
| VTGN | VistaGen Therapeutics Inc | 0.42 | -92.94% |
| TCRX | Tscan Therapeutics Inc | 0.42 | -92.93% |
| CMND | Clearmind Medicine Inc | 0.42 | -92.88% |
| VRAX | Virax Biolabs Group Ltd - Class A | 0.42 | -92.86% |
| BRNS | Barinthus Biotherapeutics Plc. | 0.43 | -92.77% |
| BOLT | Bolt Biotherapeutics Inc | 0.43 | -92.74% |
| PLRX | Pliant Therapeutics Inc | 0.43 | -92.71% |
| OGEN | Oragenics Inc | 0.44 | -92.59% |
| LITS | Lite Strategy Inc | 0.44 | -92.49% |
| BBLG | Bone Biologics Corp | 0.47 | -92.00% |
| LNAI | Lunai Bioworks Inc | 0.48 | -91.86% |
| ACET | Adicet Bio Inc | 0.49 | -91.74% |
| TIL | Instil Bio Inc | 0.49 | -91.72% |
| GLPG | Galapagos NV | 0.49 | -91.64% |
| IMA | Ikena Oncology Inc | 0.50 | -91.47% |
| BCYC | Bicycle Therapeutics Plc | 0.51 | -91.42% |
| APVO | Aptevo Therapeutics Inc | 0.51 | -91.35% |
| XBIT | XBiotech Inc | 0.54 | -90.95% |
| SLRN | Acelyrin Inc | 0.56 | -90.50% |
| SCNI | Scinai Immunotherapeutics Ltd | 0.56 | -90.47% |
| GRCE | Acasti Pharma Inc | 0.56 | -90.47% |
| CDT | CDT Equity Inc | 0.57 | -90.40% |
| INAB | IN8bio Inc | 0.59 | -90.03% |
| FBIO | Fortress Biotech Inc | 0.60 | -89.88% |
| ACHL | Achilles Therapeutics Plc | 0.61 | -89.66% |
| NKTX | Nkarta Inc | 0.62 | -89.58% |
| DWTX | Virios Therapeutics Inc | 0.63 | -89.37% |
| ORMP | Oramed Pharmaceuticals Inc | 0.64 | -89.25% |
| MURA | Mural Oncology plc | 0.64 | -89.15% |
| PMVP | PMV Pharmaceuticals Inc | 0.65 | -89.07% |
| HYPD | Eyenovia Inc | 0.65 | -88.95% |
| MBIO | Mustang Bio Inc | 0.65 | -88.93% |
| VOR | Vor Biopharma Inc | 0.66 | -88.92% |
| CDIO | Cardio Diagnostics Holdings Inc | 0.66 | -88.92% |
| CLDI | Calidi Biotherapeutics Inc | 0.66 | -88.80% |
| ACRV | Acrivon Therapeutics Inc | 0.67 | -88.63% |
| KROS | Keros Therapeutics Inc | 0.69 | -88.37% |
| AGIO | Agios Pharmaceuticals Inc | 0.69 | -88.36% |
| FULC | Fulcrum Therapeutics Inc | 0.70 | -88.12% |
| HLVX | HilleVax Inc | 0.71 | -88.01% |
| PEPG | PepGen Inc | 0.71 | -87.95% |
| TOVX | Theriva Biologics Inc | 0.72 | -87.82% |
| XLO | Xilio Therapeutics Inc | 0.72 | -87.75% |
| BGMS | Bio Green Med Solution Inc | 0.73 | -87.70% |
| LPCN | Lipocine Inc | 0.74 | -87.49% |
| DRMA | Dermata Therapeutics Inc | 0.75 | -87.38% |
| VIVS | VivoSim Labs Inc | 0.76 | -87.16% |
| ARTL | Artelo Biosciences Inc | 0.76 | -87.09% |
| PHIO | Phio Pharmaceuticals Corp | 0.77 | -87.04% |
| IMMP | Immutep Ltd | 0.78 | -86.78% |
| ATYR | Atyr Pharma Inc | 0.79 | -86.56% |
| TNXP | Tonix Pharmaceuticals Holding Corp | 0.80 | -86.39% |
| BIVI | BioVie Inc - Class A | 0.81 | -86.34% |
| NEUP | Neuphoria Therapeutics Inc | 0.81 | -86.26% |
| KPRX | Kiora Pharmaceuticals Inc | 0.84 | -85.84% |
| LENZ | LENZ Therapeutics Inc | 0.84 | -85.82% |
| BLRX | Bioline Rx Ltd | 0.84 | -85.82% |
| MBRX | Moleculin Biotech Inc | 0.85 | -85.60% |
| JANX | Janux Therapeutics Inc | 0.85 | -85.60% |
| ENSC | Ensysce Biosciences Inc | 0.85 | -85.53% |
| TRDA | Entrada Therapeutics Inc | 0.86 | -85.50% |
| RNA | Atrium Therapeutics Inc | 0.86 | -85.46% |
| ENVB | Enveric Biosciences Inc | 0.86 | -85.40% |
| THRD | Third Harmonic Bio Inc | 0.89 | -84.92% |
| VYNE | VYNE Therapeutics Inc | 0.89 | -84.90% |
| SAVA | Cassava Sciences Inc. | 0.92 | -84.40% |
| ADVM | Adverum Biotechnologies Inc | 0.93 | -84.26% |
| NBP | NovaBridge Biosciences. | 0.94 | -84.08% |
| ACXP | Acurx Pharmaceuticals Inc | 0.96 | -83.72% |
| AARD | Aardvark Therapeutics Inc | 0.98 | -83.45% |
| PRTC | PureTech Health plc American Depositary Shares | 1.00 | -82.99% |
| ALGS | Aligos Therapeutics Inc | 1.01 | -82.96% |
| FDMT | 4D Molecular Therapeutics Inc | 1.01 | -82.92% |
| INTS | Intensity Therapeutics Inc | 1.01 | -82.86% |
| XBIO | Xenetic Biosciences Inc | 1.02 | -82.76% |
| CVAC | CureVac N.V. | 1.03 | -82.60% |
| BNTX | BioNTech SE | 1.03 | -82.50% |
| BDTX | Black Diamond Therapeutics Inc | 1.04 | -82.33% |
| BCTX | BriaCell Therapeutics Corp - New | 1.04 | -82.32% |
| OKUR | Reneo Pharmaceuticals Inc - Class A | 1.05 | -82.23% |
| IMUX | Immunic Inc | 1.05 | -82.15% |
| IMRN | Immuron Ltd | 1.05 | -82.15% |
| ARCT | Arcturus Therapeutics Holdings Inc | 1.06 | -82.01% |
| ERNA | Ernexa Therapeutics Inc | 1.08 | -81.76% |
| CURX | Curanex Pharmaceuticals Inc | 1.09 | -81.52% |
| CLGN | CollPlant Biotechnologies Ltd New | 1.09 | -81.52% |
| PLRZ | Polyrizon Ltd | 1.11 | -81.22% |
| SRPT | Sarepta Therapeutics Inc | 1.11 | -81.13% |
| SABS | SAB Biotherapeutics Inc | 1.11 | -81.13% |
| CANF | Can-Fite Biopharma Ltd | 1.11 | -81.13% |
| UPB | Upstream Bio Inc | 1.12 | -81.03% |
| MTVA | MetaVia Inc | 1.12 | -81.03% |
| LYEL | Lyell Immunopharma Inc | 1.13 | -80.94% |
| CRBP | Corbus Pharmaceuticals Holdings Inc | 1.13 | -80.89% |
| RADX | Radiopharm Theranostics Ltd | 1.13 | -80.88% |
| AKTX | Akari Therapeutics Plc | 1.14 | -80.69% |
| QNRX | Quoin Pharmaceuticals Ltd | 1.16 | -80.40% |
| ARVN | Arvinas Inc | 1.17 | -80.28% |
| IBIO | iBio Inc | 1.17 | -80.22% |
| DNA | Ginkgo Bioworks Holdings Inc - Class A | 1.17 | -80.20% |
| CMMB | Chemomab Therapeutics Ltd | 1.18 | -80.06% |
| SPRC | SciSparc Ltd | 1.19 | -79.93% |
| VYGR | Voyager Therapeutics Inc | 1.19 | -79.81% |
| RCKT | Rocket Pharmaceuticals Inc | 1.19 | -79.81% |
| FATE | Fate Therapeutics Inc | 1.21 | -79.47% |
| SILO | SILO Pharma Inc | 1.22 | -79.30% |
| TARA | Protara Therapeutics Inc | 1.23 | -79.18% |
| JAGX | Jaguar Health Inc | 1.23 | -79.18% |
| ADIL | Adial Pharmaceuticals Inc | 1.23 | -79.12% |
| INVA | Innoviva Inc | 1.24 | -79.02% |
| ATOS | Atossa Therapeutics Inc | 1.25 | -78.91% |
| SNSE | Sensei Biotherapeutics Inc | 1.26 | -78.66% |
| IMRX | Immuneering Corp Class A | 1.26 | -78.66% |
| CVM | Cel-Sci Corp | 1.29 | -78.15% |
| ALXO | Alx Oncology Holdings Inc | 1.30 | -78.03% |
| CELZ | Creative Medical Technology Holdings Inc | 1.30 | -77.98% |
| IVVD | Invivyd Inc | 1.31 | -77.88% |
| VNDA | Vanda Pharmaceuticals Inc | 1.31 | -77.86% |
| IKT | Inhibikase Therapeutics Inc | 1.31 | -77.80% |
| KRRO | Korro Bio Inc | 1.31 | -77.78% |
| OABI | OmniAb Inc | 1.31 | -77.76% |
| ADXN | Addex Therapeutics Ltd | 1.32 | -77.70% |
| QNCX | Quince Therapeutics Inc | 1.33 | -77.51% |
| LXEO | Lexeo Therapeutics Inc | 1.40 | -76.29% |
| ZNTL | Zentalis Pharmaceuticals Inc | 1.40 | -76.26% |
| PASG | Passage Bio Inc | 1.41 | -76.16% |
| PRTA | Prothena Corporation plc | 1.42 | -76.02% |
| RIGL | Rigel Pharmaceuticals | 1.42 | -75.99% |
| TNYA | Tenaya Therapeutics Inc | 1.43 | -75.85% |
| MREO | Mereo Biopharma Group Plc | 1.43 | -75.83% |
| VERU | Veru Inc | 1.43 | -75.80% |
| KLRS | Kalaris Therapeutics Inc | 1.44 | -75.56% |
| CRIS | Curis Inc | 1.45 | -75.43% |
| ICU | SeaStar Medical Holding Corp | 1.45 | -75.39% |
| HOWL | Werewolf Therapeutics Inc | 1.45 | -75.39% |
| AVIR | Atea Pharmaceuticals Inc | 1.50 | -74.58% |
| HCWB | HCW Biologics Inc | 1.50 | -74.55% |
| IPSC | Century Therapeutics Inc | 1.51 | -74.51% |
| CLRB | Cellectar Biosciences Inc | 1.51 | -74.36% |
| LGVN | Longeveron Inc - Class A | 1.52 | -74.31% |
| PMN | ProMIS Neurosciences Inc | 1.52 | -74.28% |
| BBOT | BridgeBio Oncology Therapeutics Inc Com | 1.53 | -74.11% |
| GNTA | Genenta Science SpA | 1.55 | -73.82% |
| CRMD | CorMedix Inc | 1.55 | -73.75% |
| SGMT | Sagimet Biosciences Inc - Class A | 1.55 | -73.68% |
| RXRX | Recursion Pharmaceuticals Inc - Class A | 1.57 | -73.45% |
| ZURA | Zura Bio Ltd - Class A | 1.61 | -72.69% |
| MOLN | Molecular Partners AG | 1.62 | -72.52% |
| MNOV | Medicinova Inc | 1.64 | -72.31% |
| INMB | INmune Bio Inc | 1.65 | -72.14% |
| MRVI | Maravai LifeSciences Holdings Inc - Class A | 1.65 | -72.12% |
| XTLB | X.T.L. Biopharmaceuticals Ltd | 1.65 | -72.02% |
| ABCL | AbCellera Biologics Inc | 1.66 | -71.92% |
| MTNB | Matinas Biopharma Holdings Inc | 1.69 | -71.42% |
| CTNM | Contineum Therapeutics Inc - Class A | 1.69 | -71.40% |
| CCCC | C4 Therapeutics Inc | 1.69 | -71.40% |
| XNCR | Xencor Inc | 1.71 | -71.11% |
| WHWK | Whitehawk Therapeutics Inc | 1.71 | -71.04% |
| IMAB | I-Mab | 1.73 | -70.78% |
| ANTX | AN2 Therapeutics Inc | 1.73 | -70.77% |
| CRBU | Caribou Biosciences Inc | 1.73 | -70.72% |
| KAPA | Kairos Pharma Ltd | 1.73 | -70.67% |
| MRKR | Marker Therapeutics Inc | 1.74 | -70.55% |
| SLDB | Solid Biosciences Inc | 1.74 | -70.54% |
| TVRD | Cara Therapeutics Inc | 1.75 | -70.45% |
| TTNP | Titan Pharmaceuticals Inc (de) | 1.76 | -70.20% |
| VIR | Vir Biotechnology Inc | 1.76 | -70.13% |
| OLMA | Olema Pharmaceuticals Inc | 1.78 | -69.79% |
| AVXL | Anavex Life Sciences Corporation | 1.80 | -69.54% |
| BMRN | Biomarin Pharmaceutical Inc | 1.80 | -69.50% |
| SVA | Sinovac Biotech Ltd | 1.82 | -69.27% |
| RLYB | Rallybio Corp | 1.84 | -68.90% |
| CMPX | Compass Therapeutics Inc | 1.85 | -68.62% |
| ABOS | Acumen Pharmaceuticals Inc | 1.85 | -68.62% |
| NGNE | Neoleukin Therapeutics Inc | 1.86 | -68.51% |
| ORIC | ORIC Pharmaceuticals Inc | 1.87 | -68.30% |
| FBLG | FibroBiologics Inc | 1.88 | -68.13% |
| ASBP | Aspire Biopharma Holdings Inc | 1.90 | -67.85% |
| PULM | Pulmatrix Inc | 1.91 | -67.71% |
| ALT | Altimmune Inc | 1.93 | -67.36% |
| ATHE | Alterity Therapeutics Ltd | 1.97 | -66.70% |
| NAUT | Nautilus Biotechnology Inc | 1.99 | -66.34% |
| CGEN | Compugen Ltd | 2.00 | -66.17% |
| ALZN | Alzamend Neuro Inc | 2.00 | -66.10% |
| CYCN | Cyclerion Therapeutics Inc | 2.01 | -66.00% |
| GTBP | GT Biopharma Inc | 2.02 | -65.88% |
| CTMX | CytomX Therapeutics Inc | 2.03 | -65.68% |
| BNTC | Benitec Biopharma Inc | 2.03 | -65.63% |
| GPCR | Structure Therapeutics Inc | 2.04 | -65.48% |
| REGN | Regeneron Pharmaceuticals Inc | 2.06 | -65.21% |
| SER | AgeX Therapeutics Inc | 2.06 | -65.19% |
| GRDX | Entero Therapeutics Inc | 2.09 | -64.70% |
| XFOR | X4 Pharmaceuticals Inc | 2.09 | -64.66% |
| SNGX | Soligenix Inc | 2.10 | -64.55% |
| IVA | Inventiva | 2.10 | -64.41% |
| ARMP | Armata Pharmaceuticals Inc | 2.11 | -64.29% |
| STRO | Sutro Biopharma Inc | 2.11 | -64.28% |
| COYA | Coya Therapeutics Inc | 2.12 | -64.17% |
| EVAX | Evaxion Biotech A/S | 2.14 | -63.80% |
| DTIL | Precision Biosciences Inc | 2.14 | -63.78% |
| LBRX | LB Pharmaceuticals Inc | 2.15 | -63.62% |
| TRAW | Traws Pharma Inc | 2.16 | -63.40% |
| WVE | Wave Life Sciences Ltd | 2.17 | -63.26% |
| ABEO | Abeona Therapeutics Inc | 2.17 | -63.23% |
| PCSA | Processa Pharmaceuticals Inc | 2.19 | -63.01% |
| PCVX | Vaxcyte Inc | 2.19 | -62.97% |
| CGEM | Cullinan Oncology Inc | 2.21 | -62.57% |
| HRMY | Harmony Biosciences Holdings Inc | 2.26 | -61.82% |
| HIND | ReShape Lifesciences Inc | 2.26 | -61.69% |
| ASMB | Assembly Biosciences Inc | 2.26 | -61.69% |
| LRMR | Larimar Therapeutics Inc | 2.27 | -61.62% |
| MDXG | Mimedx Group Inc | 2.27 | -61.55% |
| OVID | Ovid Therapeutics Inc | 2.27 | -61.53% |
| PALI | Palisade Bio Inc | 2.29 | -61.21% |
| TECX | AvroBio Inc | 2.30 | -61.13% |
| IMTX | Immatics N.V | 2.31 | -60.96% |
| MCRB | Seres Therapeutics Inc | 2.32 | -60.76% |
| NCEL | NLS Pharmaceutics Ltd | 2.35 | -60.15% |
| PLX | Protalix BioTherapeutics Inc | 2.37 | -59.84% |
| KYTX | Kyverna Therapeutics Inc | 2.38 | -59.71% |
| PTN | Palatin Technologies Inc | 2.38 | -59.64% |
| ACOG | Alpha Cognition Inc | 2.39 | -59.54% |
| IOVA | Iovance Biotherapeutics Inc | 2.39 | -59.49% |
| EVMN | Evommune Inc | 2.42 | -59.00% |
| ALDX | Aldeyra Therapeutics Inc | 2.45 | -58.59% |
| LEXX | Lexaria Bioscience Corp | 2.50 | -57.74% |
| SRZN | Surrozen Inc | 2.50 | -57.61% |
| IMNN | Imunon Inc | 2.53 | -57.24% |
| CNTX | Context Therapeutics Inc | 2.53 | -57.12% |
| ARTV | Artiva Biotherapeutics Inc | 2.54 | -57.05% |
| MRNA | Moderna Inc | 2.54 | -57.00% |
| CRVO | CervoMed Inc | 2.55 | -56.83% |
| BCAX | Bicara Therapeutics Inc | 2.58 | -56.32% |
| CBUS | Cibus Global Ltd. Class A | 2.58 | -56.30% |
| BEAM | Beam Therapeutics Inc | 2.60 | -55.92% |
| OCS | Oculis Holding AG | 2.62 | -55.66% |
| NRSN | NeuroSense Therapeutics Ltd | 2.64 | -55.27% |
| GMAB | Genmab | 2.64 | -55.26% |
| GDTC | CytoMed Therapeutics Ltd | 2.65 | -55.09% |
| GOSS | Gossamer Bio Inc | 2.66 | -54.92% |
| GLUE | Monte Rosa Therapeutics Inc | 2.67 | -54.73% |
| NERV | Minerva Neurosciences Inc | 2.68 | -54.68% |
| BCAB | BioAtla Inc | 2.68 | -54.63% |
| CBIO | N/A | 2.68 | -54.60% |
| ALLO | Allogene Therapeutics Inc | 2.69 | -54.54% |
| PTHS | Channel Therapeutics Corporation | 2.71 | -54.05% |
| DRUG | Bright Minds Biosciences Inc | 2.73 | -53.88% |
| PBYI | Puma Biotechnology Inc | 2.78 | -52.90% |
| IDYA | Ideaya Biosciences Inc | 2.79 | -52.85% |
| CHRS | Coherus Biosciences Inc | 2.79 | -52.85% |
| CRSP | CRISPR Therapeutics AG | 2.79 | -52.72% |
| SPRO | Spero Therapeutics Inc | 2.81 | -52.43% |
| CRNX | Crinetics Pharmaceuticals Inc | 2.82 | -52.21% |
| ZLAB | Zai Lab Ltd | 2.83 | -52.18% |
| ENTA | Enanta Pharmaceuticals Inc | 2.83 | -52.07% |
| EQ | Equillium Inc | 2.84 | -51.97% |
| ANRO | Alto Neuroscience Inc | 2.84 | -51.97% |
| MAIA | MAIA Biotechnology Inc | 2.85 | -51.82% |
| LSTA | Lisata Therapeutics Inc | 2.88 | -51.35% |
| NTLA | Intellia Therapeutics Inc | 2.90 | -50.96% |
| NRXP | NRX Pharmaceuticals Inc | 2.90 | -50.86% |
| TBPH | Theravance Biopharma Inc | 2.92 | -50.52% |
| CRDF | Cardiff Oncology Inc | 2.94 | -50.33% |
| CYBN | Cybin Inc | 2.94 | -50.31% |
| FTRE | Fortrea Holdings Inc | 2.94 | -50.26% |
| ICCC | Immucell Corp | 2.98 | -49.50% |
| MNPR | Monopar Therapeutics Inc | 2.99 | -49.47% |
| ACAD | Acadia Pharmaceuticals Inc | 2.99 | -49.33% |
| MLEC | Moolec Science SA | 3.00 | -49.31% |
| RLMD | Relmada Therapeutics Inc | 3.01 | -49.11% |
| SKYE | Skye Bioscience Inc | 3.04 | -48.52% |
| XRTX | XORTX Therapeutics Inc | 3.05 | -48.45% |
| DSGN | Design Therapeutics Inc | 3.05 | -48.33% |
| AURA | Aura Biosciences Inc | 3.06 | -48.18% |
| CNTB | Connect Biopharma Holdings Ltd | 3.07 | -48.00% |
| RANI | Rani Therapeutics Holdings Inc Class A | 3.10 | -47.57% |
| PSTV | Plus Therapeutics Inc | 3.10 | -47.50% |
| GERN | Geron Corp | 3.12 | -47.17% |
| JBIO | Jade Biosciences Inc | 3.13 | -46.98% |
| RZLT | Rezolute Inc | 3.14 | -46.86% |
| MPLT | MapLight Therapeutics Inc | 3.15 | -46.64% |
| JAZZ | Jazz Pharmaceuticals plc | 3.18 | -46.22% |
| OCUL | Ocular Therapeutix Inc | 3.19 | -46.10% |
| ABUS | Arbutus Biopharma Corp | 3.23 | -45.39% |
| ABVC | ABVC BioPharma Inc | 3.23 | -45.27% |
| PHAR | Pharming Group N.V. | 3.27 | -44.61% |
| MLYS | Mineralys Therapeutics Inc | 3.28 | -44.49% |
| NRIX | Nurix Therapeutics Inc | 3.29 | -44.29% |
| REPL | Replimune Group Inc | 3.32 | -43.85% |
| BRTX | BioRestorative Therapies Inc | 3.32 | -43.80% |
| NAGE | Niagen Bioscience Inc | 3.35 | -43.36% |
| ZBIO | Zenas Biopharma Inc | 3.36 | -43.12% |
| NKTR | Nektar Therapeutics | 3.36 | -43.09% |
| MBX | MBX Biosciences Inc | 3.37 | -42.95% |
| PYXS | Pyxis Oncology Inc | 3.39 | -42.56% |
| RNXT | RenovoRx Inc | 3.40 | -42.38% |
| STTK | Shattuck Labs Inc | 3.42 | -42.17% |
| ADCT | Adc Therapeutics SA | 3.42 | -42.06% |
| COCP | Cocrystal Pharma Inc | 3.43 | -41.90% |
| ALLR | Allarity Therapeutics Inc | 3.45 | -41.63% |
| VRDN | Viridian Therapeutics Inc | 3.46 | -41.51% |
| CGTX | Cognition Therapeutics Inc | 3.46 | -41.51% |
| IMNM | Immunome Inc | 3.49 | -40.94% |
| CING | Cingulate Inc | 3.49 | -40.92% |
| NNVC | NanoViricides Inc | 3.52 | -40.52% |
| DYN | Dyne Therapeutics Inc | 3.52 | -40.50% |
| DNLI | Denali Therapeutics Inc | 3.53 | -40.23% |
| RAPP | Rapport Therapeutics Inc | 3.57 | -39.57% |
| AUPH | Aurinia Pharmaceuticals Inc | 3.58 | -39.50% |
| EPRX | Eupraxia Pharmaceuticals Inc | 3.58 | -39.43% |
| RPRX | Royalty Pharma plc - Class A | 3.58 | -39.43% |
| PRQR | ProQR Therapeutics N.V | 3.59 | -39.30% |
| IMCR | Immunocore Holdings plc | 3.61 | -38.98% |
| SEPN | Septerna Inc | 3.62 | -38.70% |
| AUTL | Autolus Therapeutics plc | 3.64 | -38.33% |
| MESO | Mesoblast Ltd | 3.65 | -38.23% |
| INCY | Incyte Corp | 3.67 | -37.93% |
| IRON | Disc Medicine Inc | 3.73 | -36.84% |
| GNFT | GENFIT S.A. American Depositary Shares | 3.77 | -36.24% |
| AVTX | Avalo Therapeutics Inc | 3.78 | -36.01% |
| ANNX | Annexon Inc | 3.78 | -36.01% |
| CPRX | Catalyst Pharmaceuticals Inc | 3.79 | -35.90% |
| TCRT | Alaunos Therapeutics Inc | 3.79 | -35.83% |
| XENE | Xenon Pharmaceuticals Inc | 3.81 | -35.46% |
| MAZE | Maze Therapeutics Inc | 3.83 | -35.20% |
| DNTH | Dianthus Therapeutics Inc | 3.85 | -34.81% |
| SPRB | Spruce Biosciences Inc | 3.85 | -34.76% |
| ZVRA | Zevra Therapeutics Inc | 3.88 | -34.36% |
| JSPR | Jasper Therapeutics Inc | 3.89 | -34.22% |
| TYRA | Tyra Biosciences Inc | 3.90 | -33.98% |
| VSTM | Verastem Inc | 3.93 | -33.44% |
| KALA | Kala Bio Inc | 4.06 | -31.29% |
| TECH | Bio-Techne Corp | 4.09 | -30.82% |
| CRVS | Corvus Pharmaceuticals Inc | 4.10 | -30.65% |
| LXRX | Lexicon Pharmaceuticals Inc | 4.12 | -30.33% |
| ESLA | Estrella Immunopharma Inc | 4.13 | -30.06% |
| KYMR | Kymera Therapeutics Inc | 4.18 | -29.30% |
| CLYM | Eliem Therapeutics Inc | 4.18 | -29.26% |
| RNAZ | TransCode Therapeutics Inc | 4.18 | -29.18% |
| ACRS | Aclaris Therapeutics Inc | 4.21 | -28.75% |
| MIST | Milestone Pharmaceuticals Inc | 4.21 | -28.70% |
| KZIA | Kazia Therapeutics Ltd | 4.25 | -28.04% |
| EYPT | EyePoint Pharmaceuticals Inc | 4.28 | -27.54% |
| NMRA | Neumora Therapeutics Inc | 4.30 | -27.25% |
| IFRX | InflaRx N.V. | 4.30 | -27.16% |
| VTVT | vTv Therapeutics Inc - Class A | 4.32 | -26.82% |
| AVBP | ArriVent BioPharma Inc | 4.39 | -25.71% |
| GRCL | Gracell Biotechnologies Inc | 4.39 | -25.69% |
| CADL | Candel Therapeutics Inc | 4.43 | -25.08% |
| MDWD | MediWound Ltd | 4.44 | -24.91% |
| CGON | Cg Oncology Inc | 4.44 | -24.91% |
| YMAB | Y-Mabs Therapeutics Inc | 4.46 | -24.53% |
| STOK | Stoke Therapeutics Inc | 4.48 | -24.12% |
| ETNB | 89bio Inc | 4.49 | -24.00% |
| BMEA | Biomea Fusion Inc | 4.50 | -23.85% |
| VERA | Vera Therapeutics Inc - Class A | 4.54 | -23.14% |
| DBVT | DBV Technologies | 4.57 | -22.66% |
| RLAY | Relay Therapeutics Inc | 4.58 | -22.53% |
| ROIV | Roivant Sciences Ltd | 4.61 | -21.92% |
| XOMA | XOMA Corp | 4.67 | -20.99% |
| IGC | IGC Pharma Inc | 4.68 | -20.85% |
| QTTB | Q32 Bio Inc | 4.71 | -20.26% |
| PRAX | Praxis Precision Medicines Inc | 4.76 | -19.48% |
| SLGL | Sol-Gel Technologies Ltd | 4.76 | -19.45% |
| TRML | Tourmaline Bio Inc | 4.77 | -19.32% |
| LGND | Ligand Pharmaceuticals Inc - Class B | 4.89 | -17.26% |
| CLDX | Celldex Therapeutics Inc | 4.92 | -16.67% |
| APGE | Apogee Therapeutics Inc | 4.96 | -16.08% |
| ELVN | Enliven Therapeutics Inc | 4.97 | -15.88% |
| NUVB | Nuvation Bio Inc - Class A | 4.99 | -15.55% |
| GANX | Gain Therapeutics Inc | 4.99 | -15.49% |
| AIM | AIM ImmunoTech Inc. | 5.01 | -15.22% |
| CLLS | Cellectis | 5.02 | -15.05% |
| ADMA | Adma Biologics Inc | 5.04 | -14.71% |
| CABA | Cabaletta Bio Inc | 5.09 | -13.86% |
| VANI | Vivani Medical Inc | 5.11 | -13.52% |
| NAMS | NewAmsterdam Pharma Company NV | 5.15 | -12.85% |
| MLTX | MoonLake Immunotherapeutics - Class A | 5.16 | -12.68% |
| CDXS | Codexis Inc | 5.19 | -12.17% |
| PRLD | Prelude Therapeutics Inc | 5.23 | -11.49% |
| ANIX | Anixa Biosciences Inc | 5.23 | -11.49% |
| GHRS | GH Research PLC | 5.30 | -10.31% |
| VCEL | Vericel Corp | 5.31 | -10.14% |
| RCUS | Arcus Biosciences Inc | 5.31 | -10.14% |
| SION | Sionna Therapeutics Inc | 5.33 | -9.80% |
| BYSI | BeyondSpring Inc | 5.38 | -8.95% |
| ENTX | Entera Bio Ltd | 5.40 | -8.61% |
| CAPR | Capricor Therapeutics Inc | 5.40 | -8.61% |
| IBO | Impact BioMedical Inc | 5.42 | -8.28% |
| CUE | Cue Biopharma Inc | 5.42 | -8.28% |
| GUTS | Fractyl Health Inc | 5.43 | -8.11% |
| ALMS | Alumis Inc | 5.43 | -8.11% |
| FBRX | Forte Biosciences Inc | 5.44 | -7.94% |
| UNCY | Unicycive Therapeutics Inc | 5.59 | -5.40% |
| GNLX | Genelux Corp | 5.60 | -5.23% |
| HURA | TuHURA Biosciences Inc | 5.61 | -5.06% |
| VALN | Valneva SE | 5.64 | -4.55% |
| LCTX | Lineage Cell Therapeutics Inc | 5.69 | -3.71% |
| KLTO | Klotho Neurosciences Inc Com | 5.71 | -3.37% |
| GYRE | Gyre Therapeutics Inc | 5.71 | -3.37% |
| SVRA | Savara Inc | 5.74 | -2.86% |
| SLN | Silence Therapeutics Plc | 5.75 | -2.69% |
| ACIU | AC Immune SA | 5.78 | -2.18% |
| ABSI | Absci Corp | 5.78 | -2.18% |
| VRTX | Vertex Pharmaceuticals Inc | 5.84 | -1.17% |
| ONC | BeiGene Ltd | 5.84 | -1.17% |
| OBIO | Orchestra BioMed Holdings Inc | 5.84 | -1.17% |
| ELDN | Eledon Pharmaceuticals Inc | 5.97 | +1.03% |
| DMAC | DiaMedica Therapeutics Inc | 6.08 | +2.89% |
| EVGN | Evogene Ltd | 6.18 | +4.59% |
| VRCA | Verrica Pharmaceuticals Inc | 6.20 | +4.92% |
| CMRX | Chimerix Inc | 6.30 | +6.54% |
| PVLA | Palvella Therapeutics Inc | 6.31 | +6.79% |
| NTRB | Nutriband Inc | 6.31 | +6.79% |
| PRME | Prime Medicine Inc | 6.38 | +7.97% |
| SANA | Sana Biotechnology Inc | 6.56 | +11.02% |
| ADAG | Adagene Inc | 6.67 | +12.88% |
| LEGN | Legend Biotech Corp | 6.70 | +13.39% |
| VKTX | Viking Therapeutics Inc | 6.76 | +14.40% |
| EXEL | Exelixis Inc | 6.83 | +15.59% |
| BLTE | Belite Bio Inc | 6.88 | +16.43% |
| IMMX | Immix Biopharma Inc | 6.89 | +16.60% |
| CALC | CalciMedica Inc | 6.98 | +18.12% |
| ATAI | ATAI Life Sciences N.V. | 7.00 | +18.46% |
| HYFT | MindWalk Holdings Corp | 7.02 | +18.80% |
| SLXN | Silexion Therapeutics Corp | 7.07 | +19.65% |
| EWTX | Edgewise Therapeutics Inc | 7.18 | +21.51% |
| CVKD | Cadrenal Therapeutics Inc | 7.23 | +22.35% |
| KURA | Kura Oncology Inc | 7.25 | +22.69% |
| CAMP | CAMP4 Therapeutics Corp | 7.29 | +23.37% |
| TSHA | Taysha Gene Therapies Inc | 7.32 | +23.88% |
| KRYS | Krystal Biotech Inc | 7.34 | +24.22% |
| TELO | Telomir Pharmaceuticals Inc | 7.38 | +24.89% |
| ARGX | Argen X SE | 7.51 | +27.09% |
| TARS | Tarsus Pharmaceuticals Inc | 7.55 | +27.77% |
| IMVT | Immunovant Inc | 7.61 | +28.79% |
| TLX | Telix Pharmaceuticals Ltd | 7.67 | +29.80% |
| APLT | Applied Therapeutics Inc | 7.72 | +30.65% |
| ORKA | ARCA biopharma Inc | 7.98 | +35.05% |
| ACHV | Achieve Life Sciences Inc | 7.99 | +35.22% |
| FENC | Fennec Pharmaceuticals Inc | 8.08 | +36.74% |
| PHVS | Pharvaris NV | 8.09 | +36.91% |
| APLM | Apollomics Inc - Class A | 8.15 | +37.92% |
| CAI | Caris Life Sciences Inc - Class A | 8.17 | +38.26% |
| NUVL | Nuvalent Inc - Class A | 8.30 | +40.46% |
| XCUR | Exicure Inc | 8.39 | +41.99% |
| AAPG | Ascentage Pharma Group International | 8.40 | +42.15% |
| OMER | Omeros Corporation | 8.44 | +42.83% |
| ARDX | Ardelyx Inc | 9.29 | +57.22% |
| HRTX | Heron Therapeutics Inc | 9.36 | +58.40% |
| COGT | Cogent Biosciences Inc | 9.87 | +67.03% |
| CELU | Celularity Inc - Class A | 9.89 | +67.37% |
| PYPD | Polypid Ltd | 9.98 | +68.89% |
| LIXT | Lixte Biotechnology Holdings Inc | 10.01 | +69.40% |
| PTGX | Protagonist Therapeutics Inc | 10.39 | +75.83% |
| ZYME | Zymeworks BC Inc | 10.47 | +77.19% |
| ERAS | Erasca Inc | 10.57 | +78.88% |
| TNGX | Tango Therapeutics Inc | 10.60 | +79.39% |
| SNTI | Senti Biosciences Inc | 11.00 | +86.15% |
| TRVI | Trevi Therapeutics Inc | 11.05 | +87.00% |
| QURE | uniQure N.V. | 11.17 | +89.03% |
| INKT | MiNK Therapeutics Inc | 11.33 | +91.74% |
| TGTX | TG Therapeutics Inc | 11.38 | +92.59% |
| MGNX | Macrogenics Inc | 11.60 | +96.31% |
| DRTS | Alpha Tau Medical Ltd | 12.02 | +103.42% |
| KPTI | Karyopharm Therapeutics Inc | 12.05 | +103.92% |
| CORT | Corcept Therapeutics Inc | 12.22 | +106.80% |
| BCDA | BioCardia Inc | 12.35 | +109.00% |
| ACTU | Actuate Therapeutics Inc | 12.58 | +112.89% |
| CNTA | Centessa Pharmaceuticals plc | 12.60 | +113.23% |
| SYRE | Spyre Therapeutics Inc | 12.66 | +114.25% |
| BHVN | Biohaven Ltd | 12.87 | +117.80% |
| SLS | SELLAS Life Sciences Group Inc | 13.09 | +121.52% |
| OSTX | OS Therapies Inc | 13.65 | +131.00% |
| ATNM | Actinium Pharmaceuticals Inc | 13.75 | +132.69% |
| OKYO | OKYO Pharma Ltd - New | 14.11 | +138.79% |
| GOVX | Geovax Labs Inc | 14.14 | +139.29% |
| LTRN | Lantern Pharma Inc | 14.37 | +143.19% |
| INO | Inovio Pharmaceuticals Inc | 14.44 | +144.37% |
| NRXS | Neuraxis Inc | 14.66 | +148.09% |
| LPTX | Leap Therapeutics Inc | 14.83 | +150.90% |
| SPRY | ARS Pharmaceuticals Inc | 14.98 | +153.51% |
| ARQT | Arcutis Biotherapeutics Inc | 15.02 | +154.19% |
| PDSB | PDS Biotechnology Corporation | 15.20 | +157.23% |
| RGNX | Regenxbio Inc | 15.50 | +162.31% |
| ABVX | Abivax | 15.80 | +167.39% |
| ATRA | Atara Biotherapeutics Inc | 16.14 | +173.14% |
| ALEC | Alector Inc | 16.31 | +176.02% |
| ARWR | Arrowhead Pharmaceuticals Inc | 16.77 | +183.80% |
| KOD | Kodiak Sciences Inc | 17.53 | +196.66% |
| CSBR | Champions Oncology Inc | 18.32 | +210.03% |
| SRRK | Scholar Rock Holding Corp | 19.14 | +223.91% |
| NVCT | Nuvectis Pharma Inc | 19.23 | +225.43% |
| URGN | UroGen Pharma Ltd | 19.27 | +226.11% |
| IPHA | Innate Pharma | 20.10 | +240.16% |
| MDGL | Madrigal Pharmaceuticals Inc | 20.25 | +242.69% |
| SMMT | Summit Therapeutics Inc | 20.32 | +243.88% |
| RVMD | Revolution Medicines Inc | 20.43 | +245.74% |
| DYAI | Dyadic International Inc DE | 21.01 | +255.56% |
| MTSR | Metsera Inc | 21.96 | +271.63% |
| TLSA | Tiziana Life Sciences Ltd | 22.09 | +273.83% |
| ANVS | Annovis Bio Inc | 22.61 | +282.63% |
| TPST | Tempest Therapeutics Inc | 23.24 | +293.29% |
| ASND | Ascendis Pharma A/S | 23.43 | +296.51% |
| MIRM | Mirum Pharmaceuticals Inc | 23.64 | +300.06% |
| IRD | Ocuphire Pharma Inc | 23.82 | +303.11% |
| IONS | Ionis Pharmaceuticals Inc | 25.08 | +324.43% |
| PHAT | Phathom Pharmaceuticals Inc | 25.37 | +329.34% |
| EDSA | Edesa Biotech Inc | 25.43 | +330.36% |
| HUMA | Humacyte Inc | 25.79 | +336.45% |
| TTRX | Turn Therapeutics Inc | 26.93 | +355.74% |
| RNTX | Rein Therapeutics Inc | 28.17 | +376.73% |
| INSM | Insmed Inc | 28.97 | +390.26% |
| RNAC | Cartesian Therapeutics Inc | 31.26 | +429.02% |
| NVAX | Novavax Inc | 33.20 | +461.85% |
| ALNY | Alnylam Pharmaceuticals Inc | 36.96 | +525.48% |
| SNDX | Syndax Pharmaceuticals Inc | 37.64 | +536.99% |
| OTLK | Outlook Therapeutics Inc | 38.42 | +550.19% |
| HALO | Halozyme Therapeutics Inc | 38.61 | +553.40% |
| ANL | Adlai Nortye Ltd | 38.65 | +554.12% |
| DARE | Dare Bioscience Inc | 39.19 | +563.22% |
| QNTM | FSD Pharma Inc - Class B - Class B (Sub Voting) | 42.25 | +615.00% |
| TVTX | Travere Therapeutics Inc | 44.03 | +645.13% |
| EXOZ | Invizyne Technologies Inc | 46.03 | +678.97% |
| RYTM | Rhythm Pharmaceuticals Inc | 49.01 | +729.40% |
| KALV | KalVista Pharmaceuticals Inc | 49.03 | +729.74% |
| CYTK | Cytokinetics Inc | 60.31 | +920.64% |
| GLSI | Greenwich LifeSciences Inc | 61.61 | +942.64% |
| NBTX | Nanobiotix | 65.02 | +1000.34% |
| YDES | YD Bio Ltd | 66.53 | +1025.90% |
| PGEN | Precigen Inc | 68.45 | +1058.39% |
| OCGN | Ocugen Inc | 69.69 | +1079.37% |
| CELC | Celcuity Inc | 84.24 | +1325.61% |
| PROK | ProKidney Corp - Class A | 100.75 | +1604.98% |
| CNSP | Cns Pharmaceuticals Inc | 106.55 | +1703.16% |
| ANAB | AnaptysBio Inc | 117.87 | +1894.73% |
| EDIT | Editas Medicine Inc | 123.59 | +1991.53% |
| BBIO | BridgeBio Pharma Inc | 123.68 | +1993.06% |
| ELTX | Elicio Therapeutics Inc | 132.74 | +2146.38% |
| MNKD | Mannkind Corp | 187.85 | +3079.01% |
| GALT | Galectin Therapeutics Inc | 207.70 | +3414.94% |
| INBX | Inhibrx Biosciences Inc | 212.28 | +3492.45% |
| INDP | Indaptus Therapeutics Inc | 216.89 | +3570.46% |
| AGEN | Agenus Inc | 218.61 | +3599.57% |
| JUNS | Jupiter Neurosciences Inc | 227.66 | +3752.72% |
| MGTX | MeiraGTx Holdings plc | 228.30 | +3763.56% |
| AXSM | Axsome Therapeutics Inc | 231.57 | +3818.89% |
| RARE | Ultragenyx Pharmaceutical Inc | 247.70 | +4091.86% |
| VRNA | Verona Pharma Plc | 279.39 | +4628.20% |
| PLUR | Pluri Inc | 306.56 | +5087.96% |
| ONCY | Oncolytics Biotech Inc | 1055.04 | +17754.60% |
| PTCT | PTC Therapeutics Inc | 1743.27 | +29401.62% |
| FHTX | Foghorn Therapeutics Inc | 2005.35 | +33836.84% |